Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 38% ± 11% | |
lung | 17 studies | 36% ± 16% | |
intestine | 12 studies | 27% ± 13% | |
eye | 9 studies | 50% ± 20% | |
brain | 8 studies | 26% ± 11% | |
kidney | 7 studies | 40% ± 9% | |
liver | 7 studies | 27% ± 9% | |
lymph node | 6 studies | 35% ± 10% | |
bone marrow | 5 studies | 26% ± 9% | |
uterus | 5 studies | 30% ± 12% | |
pancreas | 4 studies | 58% ± 24% | |
placenta | 4 studies | 40% ± 24% | |
breast | 4 studies | 25% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5735.15 | 1445 / 1445 | 100% | 105.49 | 183 / 183 |
ovary | 100% | 2775.49 | 180 / 180 | 100% | 81.83 | 430 / 430 |
brain | 100% | 4634.55 | 2636 / 2642 | 100% | 87.30 | 703 / 705 |
stomach | 99% | 2317.15 | 357 / 359 | 100% | 61.63 | 285 / 286 |
lung | 99% | 2711.35 | 574 / 578 | 100% | 76.73 | 1150 / 1155 |
intestine | 100% | 3228.54 | 966 / 966 | 99% | 57.26 | 521 / 527 |
skin | 100% | 6332.86 | 1808 / 1809 | 99% | 65.95 | 465 / 472 |
breast | 100% | 2740.83 | 459 / 459 | 98% | 53.94 | 1099 / 1118 |
uterus | 100% | 2812.25 | 170 / 170 | 98% | 78.44 | 450 / 459 |
bladder | 100% | 3377.24 | 21 / 21 | 97% | 65.32 | 490 / 504 |
kidney | 100% | 3117.56 | 89 / 89 | 97% | 83.81 | 875 / 901 |
prostate | 100% | 2337.68 | 244 / 245 | 95% | 33.61 | 478 / 502 |
thymus | 100% | 2014.66 | 650 / 653 | 95% | 33.94 | 575 / 605 |
adrenal gland | 100% | 6036.91 | 258 / 258 | 90% | 61.19 | 208 / 230 |
liver | 95% | 1973.67 | 215 / 226 | 89% | 28.44 | 360 / 406 |
pancreas | 73% | 834.28 | 241 / 328 | 98% | 44.47 | 174 / 178 |
adipose | 100% | 3081.86 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 90.05 | 29 / 29 |
spleen | 100% | 2891.97 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 97.26 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 21.82 | 1 / 1 |
blood vessel | 100% | 3618.25 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 8599.10 | 922 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 43.27 | 77 / 80 |
heart | 93% | 3365.29 | 802 / 861 | 0% | 0 | 0 / 0 |
muscle | 41% | 418.38 | 330 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0061621 | Biological process | canonical glycolysis |
GO_0006094 | Biological process | gluconeogenesis |
GO_0034774 | Cellular component | secretory granule lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0046538 | Molecular function | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity |
GO_0016787 | Molecular function | hydrolase activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0004619 | Molecular function | phosphoglycerate mutase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004082 | Molecular function | bisphosphoglycerate mutase activity |
Gene name | PGAM1 |
Protein name | Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B) Phosphoglycerate mutase (EC 5.4.2.11) (EC 5.4.2.4) |
Synonyms | CDABP0006 hCG_25778 hCG_2015269 HEL-S-35 PGAMA |
Description | FUNCTION: Catalyzes the interconversion of 2-phosphoglycerate and 3-phosphoglyceratea crucial step in glycolysis, by using 2,3-bisphosphoglycerate . Also catalyzes the interconversion of (2R)-2,3-bisphosphoglycerate and (2R)-3-phospho-glyceroyl phosphate . . |
Accessions | Q6FHK8 ENST00000334828.6 Q6FHU2 P18669 Q6P6D7 Q0D2Q6 |